References
- HamiltonMA rating scale for depressionJ Neurol Neurosurg Psychiatry196023566214399272
- CiprianiAFurukawaTASalantiGComparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysisLancet2009373966574675819185342
- RamsbergJAsseburgCHenrikssonMEffectiveness and cost-effectiveness of antidepressants in primary care: a multiple treatment comparison meta-analysis and cost-effectiveness modelPLoS One201278e4200322876296
- Ai Report 2011 -chikenyakunenpou-[The sales amounts of antidepressants in Japan]CIMA Sci J2011
- BoulengerJPHuusomAKFloreaIBaekdalTSarchiaponeMA comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patientsCurr Med Res Opin20062271331134116834832
- KasperSBaldwinDSLarsson LonnSBoulengerJPSuperiority of escitalopram to paroxetine in the treatment of depressionEur Neuropsychopharmacol200919422923719185467
- BaldwinDSCooperJAHuusomAKHindmarchIA double-blind, randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorderInt Clin Psychopharmacol200621315916916528138
- NICEDepression in Adults: Recognition and Management. [Last updated: April 2016]National Institute for Health and Care Excellence2009
- GoldenRNNemeroffCBMcSorleyPPittsCDDubeEMEfficacy and tolerability of controlled-release and immediate-release paroxetine in the treatment of depressionJ Clin Psychiatry200263757758412143913
- JordanSKnightJPointonDMonitoring adverse drug reactions: scales, profiles, and checklistsInt Nurs Rev200451420822115530161
- RiedelMMollerHJObermeierMResponse and remission criteria in major depression – a validation of current practiceJ Psychiatr Res201044151063106820447651
- HayasakaYPurgatoMMagniLRDose equivalents of antidepressants: evidence-based recommendations from randomized controlled trialsJ Affect Disord201518017918425911132
- KhooALZhouHJTengMNetwork meta-analysis and cost-effectiveness analysis of new generation antidepressantsCNS Drugs201529869571226293743
- PernegerTVWhat’s wrong with Bonferroni adjustmentsBMJ19983167139123612389553006
- SankohAJHuqueMFDubeySDSome comments on frequently used multiple endpoint adjustment methods in clinical trialsStat Med19971622252925429403954
- MallinckrodtCHKaiserCJWatkinJGMolenberghsGCarrollRJThe effect of correlation structure on treatment contrasts estimated from incomplete clinical trial data with likelihood-based repeated measures compared with last observation carried forward ANOVAClin Trials20041647748916279288